BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8062452)

  • 1. Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein.
    Eggleton P; Lieu TS; Zappi EG; Sastry K; Coburn J; Zaner KS; Sontheimer RD; Capra JD; Ghebrehiwet B; Tauber AI
    Clin Immunol Immunopathol; 1994 Sep; 72(3):405-9. PubMed ID: 8062452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of calreticulin from neutrophils may alter C1q-mediated immune functions.
    Kishore U; Sontheimer RD; Sastry KN; Zaner KS; Zappi EG; Hughes GR; Khamashta MA; Strong P; Reid KB; Eggleton P
    Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):543-50. PubMed ID: 9065775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1q inhibits autoantibody binding to calreticulin.
    Racila DM; Sontheimer RD
    Lupus; 1999; 8(4):300-4. PubMed ID: 10413209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of C1q and the collectins with the potential receptors calreticulin (cC1qR/collectin receptor) and megalin.
    Sim RB; Moestrup SK; Stuart GR; Lynch NJ; Lu J; Schwaeble WJ; Malhotra R
    Immunobiology; 1998 Aug; 199(2):208-24. PubMed ID: 9777407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
    Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
    Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).
    van den Berg RH; Siegert CE; Faber-Krol MC; Huizinga TW; van Es LA; Daha MR
    Clin Exp Immunol; 1998 Feb; 111(2):359-64. PubMed ID: 9486404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement component C1 and the collectins--first-line defense molecules in innate and acquired immunity.
    Reid KB; Colomb M; Petry F; Loos M
    Trends Immunol; 2002 Mar; 23(3):115-7. PubMed ID: 11864828
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R.
    Eggleton P; Ghebrehiwet B; Sastry KN; Coburn JP; Zaner KS; Reid KB; Tauber AI
    J Clin Invest; 1995 Apr; 95(4):1569-78. PubMed ID: 7706463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.
    Ogden CA; deCathelineau A; Hoffmann PR; Bratton D; Ghebrehiwet B; Fadok VA; Henson PM
    J Exp Med; 2001 Sep; 194(6):781-95. PubMed ID: 11560994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localisation of the C1q binding site within C1q receptor/calreticulin.
    Stuart GR; Lynch NJ; Lu J; Geick A; Moffatt BE; Sim RB; Schwaeble WJ
    FEBS Lett; 1996 Nov; 397(2-3):245-9. PubMed ID: 8955356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collectins and collectin receptors in innate immunity.
    Holmskov UL
    APMIS Suppl; 2000; 100():1-59. PubMed ID: 11021254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes.
    Kishore U; Sontheimer RD; Sastry KN; Zappi EG; Hughes GR; Khamashta MA; Reid KB; Eggleton P
    Clin Exp Immunol; 1997 May; 108(2):181-90. PubMed ID: 9158084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C1q and collectin binding site within C1q receptor (cell surface calreticulin).
    Stuart GR; Lynch NJ; Day AJ; Schwaeble WJ; Sim RB
    Immunopharmacology; 1997 Dec; 38(1-2):73-80. PubMed ID: 9476117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization.
    Peterson KL; Zhang W; Lu PD; Keilbaugh SA; Peerschke EI; Ghebrehiwet B
    Clin Immunol Immunopathol; 1997 Jul; 84(1):17-26. PubMed ID: 9191880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of C1q with the receptor calreticulin requires a conformational change in C1q.
    Steinø A; Jørgensen CS; Laursen I; Houen G
    Scand J Immunol; 2004 May; 59(5):485-95. PubMed ID: 15140059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A calreticulin-like molecule from the human hookworm Necator americanus interacts with C1q and the cytoplasmic signalling domains of some integrins.
    Kasper G; Brown A; Eberl M; Vallar L; Kieffer N; Berry C; Girdwood K; Eggleton P; Quinnell R; Pritchard DI
    Parasite Immunol; 2001 Mar; 23(3):141-52. PubMed ID: 11240905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human autoantibodies against Clq: lack of cross reactivity with the collectins mannan-binding protein, lung surfactant protein A and bovine conglutinin.
    Mårtensson U; Thiel S; Jensenius JC; Sjöholm AG
    Scand J Immunol; 1996 Mar; 43(3):314-20. PubMed ID: 8602466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface calreticulin is a putative mannoside lectin which triggers mouse melanoma cell spreading.
    White TK; Zhu Q; Tanzer ML
    J Biol Chem; 1995 Jul; 270(27):15926-9. PubMed ID: 7608143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading.
    Feng X; Tonnesen MG; Peerschke EI; Ghebrehiwet B
    J Immunol; 2002 Mar; 168(5):2441-8. PubMed ID: 11859136
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Shao S; Hao C; Zhan B; Zhuang Q; Zhao L; Chen Y; Huang J; Zhu X
    Front Immunol; 2020; 11():572326. PubMed ID: 33329535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.